Kymera Therapeutics, Inc. Balance Sheet

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Current Assets
Cash & Equivalents 76.02M31.00M47.98M68.39M109.97M120.26M
Short-term Investments 15.94M265.20M394.44M338.77M264.92M368.49M
Cash & Current Investments 91.96M296.20M442.42M407.17M374.88M488.74M
Receivables - Net 0.60M15.00M
Receivables - Other 0.86M0.14M2.54M3.80M0.95M
Receivables 1.46M18.80M
Prepaid Assets 0.89M4.70M8.72M9.71M11.67M20.58M
Current Assets 92.84M302.34M451.27M419.42M405.32M510.27M
Non-Current Assets
Property, Plant & Equipment (Net) 3.79M10.84M11.88M13.33M48.13M50.46M
Long-Term Investments 162.53M125.20M152.33M61.43M362.20M
Other Non-Current Assets 1.77M1.59M6.12M6.13M5.81M5.79M
Non-Current Assets 23.86M184.84M154.63M183.72M170.44M467.77M
Assets 116.70M487.18M605.90M603.13M575.76M978.03M
Liabilities
Current Liabilities
Accounts Payables 3.28M4.37M4.00M4.33M7.08M5.99M
Payables 3.28M4.37M4.00M4.33M7.08M5.99M
Accumulated Expenses 4.57M10.33M22.97M27.50M33.86M34.87M
Other Accumulated Expenses 2.62M5.82M15.17M16.98M15.10M17.80M
Current Leases 2.70M2.57M2.46M2.54M5.07M11.59M
Current Deferred Revenue 52.99M170.39M101.03M63.26M54.65M13.58M
Total Current Liabilities 34.57M110.62M92.54M71.34M85.69M67.77M
Non-Current Liabilities
Capital Leases 1.17M0.60M1.14M1.25M1.30M2.23M
Non-Current Deffered Revenue 29.64M77.84M39.30M28.00M16.77M
Preferred Stock Liabilities 59.92M
Operating Leases 16.65M14.13M13.22M12.15M77.03M72.42M
Other Non-Current Liabilities 0.10M0.07M0.25M
Total Non-Current Liabilities 203.19M146.20M112.73M
Total Liabilities 82.03M203.29M146.27M112.98M180.79M142.42M
Shareholder's Equity
Common Equity -74.41M283.89M459.64M490.15M394.97M835.62M
Shareholder's Equity -74.41M283.89M459.64M490.15M394.97M835.62M
Liabilities and Shareholders Equity 116.70M487.18M605.90M603.13M575.76M978.03M
Retained Earnings -76.46M-128.76M-228.98M-383.79M-530.75M-754.61M
Treasury Shares 0.23M0.11M0.04M0.28M0.59M0.75M